tirzepatide vs semaglutide differences mechanism Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management Semaglutide vs Tirzepatide Differences

( J ) The potency of TZP to recruit ARRB2 to GLP-1R is difficult to determine due to low efficacy ( n = 5), while GLP-1(7-36) is a full agonist with an EC 50 of 3.26 nM (0.71, 14).

Convenience of Administration It is administered via subcutaneous injection, typically once a week

A clean kitchen counter works

A key difference between the two drugs is that Zepbound is a dual receptor agonist that works on both GLP-1 and gastric inhibitory polypeptide (GIP)

List of Sources Overview of Tirzepatide and Retatrutide Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study ( news.weill.cornell.edu ( axios.com ( Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine | Eli Lilly and Company ( Mechanisms of Action: How Each Medication Works tctmd.com ( Study directly compares Zepbound and Wegovy for weight-loss results ( Pennington Biomedical Research Center Investigates Tirzepatides Role in Weight Loss and Metabolic Health ( news.weill.cornell.edu ( eurekalert.org ( Comparative Efficacy: Weight Loss Outcomes The weight-loss drugs being tested in 2025: will they beat Ozempic